Dorthe Mejer - Fluoguide VP Devel

All Insiders . Sweden . 
Stock . Fluoguide AS . Stakeholders . Insider . Dorthe Mejer
FLUO Stock  SEK 39.90  3.00  8.13%   

Insider

Dorthe Mejer is VP Devel of Fluoguide AS
Phone45 31 22 66 60
Webhttps://fluoguide.com

Fluoguide Management Efficiency

The company has return on total asset (ROA) of (0.3815) % which means that it has lost $0.3815 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5643) %, meaning that it generated substantial loss on money invested by shareholders. Fluoguide's management efficiency ratios could be used to measure how well Fluoguide manages its routine affairs as well as how well it operates its assets and liabilities.
Fluoguide AS has accumulated 138 K in total debt with debt to equity ratio (D/E) of 0.0, which may suggest the company is not taking enough advantage from borrowing. Fluoguide AS has a current ratio of 5.46, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Fluoguide until it has trouble settling it off, either with new capital or with free cash flow. So, Fluoguide's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Fluoguide AS sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Fluoguide to invest in growth at high rates of return. When we think about Fluoguide's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Mette ThornExpreS2ion Biotech Holding
N/A
Anthony PareBioPorto
60
Neil CPABioPorto
55
Klaus SindahlHansa Biopharma AB
N/A
EjvindgensencBrain AS
N/A
Bent MScExpreS2ion Biotech Holding
N/A
Nis KruseBioPorto
N/A
Katja MargellHansa Biopharma AB
N/A
Anne LannerHansa Biopharma AB
54
Niels KristensencBrain AS
N/A
Gry LarsenBioPorto
N/A
Emanuel BjrneHansa Biopharma AB
50
Lars PetersenExpreS2ion Biotech Holding
N/A
Christopher BirdBioPorto
N/A
Lars UttenthalBioPorto
N/A
Jennifer ZondermanBioPorto
N/A
Keith AlexanderExpreS2ion Biotech Holding
N/A
Sren MScHansa Biopharma AB
58
Mattis RantheExpreS2ion Biotech Holding
N/A
Tony SummerlincBrain AS
N/A
Max SogaardExpreS2ion Biotech Holding
N/A
FluoGuide AS, a life science company, engages in the development and sale of surgical solutions in Denmark. The company was founded in 2018 and is based in Copenhagen, Denmark. FluoGuide is traded on Stockholm Stock Exchange in Sweden. Fluoguide AS (FLUO) is traded on Stockholm Exchange in Sweden and employs 5 people.

Management Performance

Return On Equity-0.56
Return On Asset-0.38

Fluoguide AS Leadership Team

Elected by the shareholders, the Fluoguide's board of directors comprises two types of representatives: Fluoguide inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Fluoguide. The board's role is to monitor Fluoguide's management team and ensure that shareholders' interests are well served. Fluoguide's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Fluoguide's outside directors are responsible for providing unbiased perspectives on the board's policies.
MD MSc, CMO, CSO
BBA MD, Chief Officer
Henrik Hang, Chief Officer
Grethe MSc, Chief Officer
Dorthe Mejer, VP Devel

Fluoguide Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Fluoguide a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.56
Return On Asset-0.38
Current Valuation497.47 M
Shares Outstanding11.81 M
Shares Owned By Insiders42.46 %
Shares Owned By Institutions9.27 %
Price To Book8.86 X
Price To Sales348.55 X
EBITDA(28.9 M)
Net Income(23.77 M)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Fluoguide Stock Analysis

When running Fluoguide's price analysis, check to measure Fluoguide's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fluoguide is operating at the current time. Most of Fluoguide's value examination focuses on studying past and present price action to predict the probability of Fluoguide's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fluoguide's price. Additionally, you may evaluate how the addition of Fluoguide to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY